Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coli
- PMID: 3026239
- PMCID: PMC176532
- DOI: 10.1128/AAC.30.5.777
Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coli
Abstract
Subunit A and B proteins of DNA gyrase were separately purified from fluoroquinolone-resistant Escherichia coli GN14181 (MIC of ofloxacin, 100 micrograms/ml) and susceptible strain KL-16. The supercoiling activities of reconstituted Ar+Br (r, resistant) and Ar+Bs (s, susceptible) were 250-fold more resistant to new fluoroquinolones than those of As+Bs and As+Br.
Similar articles
-
Purification of Citrobacter freundii DNA gyrase and inhibition by quinolones.Antimicrob Agents Chemother. 1988 Jan;32(1):104-9. doi: 10.1128/AAC.32.1.104. Antimicrob Agents Chemother. 1988. PMID: 2831810 Free PMC article.
-
Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases.Antimicrob Agents Chemother. 1996 Dec;40(12):2714-20. doi: 10.1128/AAC.40.12.2714. Antimicrob Agents Chemother. 1996. PMID: 9124828 Free PMC article.
-
Inhibitory effects of ciprofloxacin and sparfloxacin on DNA gyrase purified from fluoroquinolone-resistant strains of methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother. 1991 Nov;35(11):2288-93. doi: 10.1128/AAC.35.11.2288. Antimicrob Agents Chemother. 1991. PMID: 1666495 Free PMC article.
-
DNA gyrase as a drug target.Biochem Soc Trans. 1999 Feb;27(2):48-53. doi: 10.1042/bst0270048. Biochem Soc Trans. 1999. PMID: 10093705 Review. No abstract available.
-
[Fluoroquinolones and Gram-negative bacteria: antimicrobial activity and mechanisms of resistance].Infez Med. 2008 Apr;16 Suppl2:5-11. Infez Med. 2008. PMID: 18843219 Review. Italian.
Cited by
-
Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone.Antimicrob Agents Chemother. 1993 Apr;37(4):793-800. doi: 10.1128/AAC.37.4.793. Antimicrob Agents Chemother. 1993. PMID: 8388199 Free PMC article.
-
Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus.Antimicrob Agents Chemother. 1991 Feb;35(2):368-70. doi: 10.1128/AAC.35.2.368. Antimicrob Agents Chemother. 1991. PMID: 2024969 Free PMC article.
-
Biochemical characteristics and physiological significance of major DNA topoisomerases.Antimicrob Agents Chemother. 1989 Dec;33(12):2027-33. doi: 10.1128/AAC.33.12.2027. Antimicrob Agents Chemother. 1989. PMID: 2559654 Free PMC article. Review. No abstract available.
-
Design, synthesis and biological evaluation of novel flavone Mannich base derivatives as potential antibacterial agents.Mol Divers. 2019 May;23(2):299-306. doi: 10.1007/s11030-018-9873-9. Epub 2018 Aug 30. Mol Divers. 2019. PMID: 30168050
-
Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation.Antimicrob Agents Chemother. 1989 Mar;33(3):283-90. doi: 10.1128/AAC.33.3.283. Antimicrob Agents Chemother. 1989. PMID: 2658782 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials